Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Diabetes, Obesity & Metabolism
|
January 4, 2022
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials
Lawrence A Leiter, Maciej Banach, Alberico L Catapano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 7, 2024
Lipoprotein Apheresis: Utility, Outcomes, and Implementation in Clinical Practice: A Scientific Statement From the American Heart Association
Eugenia Gianos, P Barton Duell, Peter P Toth, et al.
Atherosclerosis
|
April 19, 2023
Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials
Erik S G Stroes, Harold E Bays, Maciej Banach, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 29, 2025
Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective-Brief Report
Michael J Wilkinson, Priyesha Bijlani, Michael H Davidson, et al.
The Journal of the Association of Physicians of India
|
March 12, 2026
Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study
Vimal Mehta, Nikhil Agarwal, Pratishtha Mehra, et al.
Journal of Lipid Research
|
September 15, 2019
Partial <i>LPL</i> deletions: rare copy-number variants contributing towards severe hypertriglyceridemia
Jacqueline S Dron, Jian Wang, Adam D McIntyre, et al.
Journal of Lipid Research
|
April 23, 2021
Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis
Philip Höflinger, Stefan Hauser, Eylan Yutuc, et al.
Journal of Clinical Lipidology
|
May 22, 2016
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
Patrick M Moriarty, Klaus G Parhofer, Stephan P Babirak, et al.
Journal of the American College of Cardiology
|
October 1, 2021
Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory Antibodies
Carlota Oleaga, Michael D Shapiro, Joshua Hay, et al.
Journal of Clinical Lipidology
|
June 24, 2025
Lipoprotein X - Pathophysiology, diagnosis, and management
Dinesh K Kalra, Matthew Shotwell, Abhimanyu Garg, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Diabetes, Obesity & Metabolism
|
January 4, 2022
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials
Lawrence A Leiter, Maciej Banach, Alberico L Catapano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 7, 2024
Lipoprotein Apheresis: Utility, Outcomes, and Implementation in Clinical Practice: A Scientific Statement From the American Heart Association
Eugenia Gianos, P Barton Duell, Peter P Toth, et al.
Atherosclerosis
|
April 19, 2023
Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials
Erik S G Stroes, Harold E Bays, Maciej Banach, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 29, 2025
Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective-Brief Report
Michael J Wilkinson, Priyesha Bijlani, Michael H Davidson, et al.
The Journal of the Association of Physicians of India
|
March 12, 2026
Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study
Vimal Mehta, Nikhil Agarwal, Pratishtha Mehra, et al.
Journal of Lipid Research
|
September 15, 2019
Partial <i>LPL</i> deletions: rare copy-number variants contributing towards severe hypertriglyceridemia
Jacqueline S Dron, Jian Wang, Adam D McIntyre, et al.
Journal of Lipid Research
|
April 23, 2021
Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis
Philip Höflinger, Stefan Hauser, Eylan Yutuc, et al.
Journal of Clinical Lipidology
|
May 22, 2016
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
Patrick M Moriarty, Klaus G Parhofer, Stephan P Babirak, et al.
Journal of the American College of Cardiology
|
October 1, 2021
Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory Antibodies
Carlota Oleaga, Michael D Shapiro, Joshua Hay, et al.
Journal of Clinical Lipidology
|
June 24, 2025
Lipoprotein X - Pathophysiology, diagnosis, and management
Dinesh K Kalra, Matthew Shotwell, Abhimanyu Garg, et al.
Page
of 9